StockTipsArenaBeta

SELL Glenmark Pharmaceuticals — ICICI Securities

SELLGlenmark Pharmaceuticals
Glenmark Pharmaceuticals share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)18 Jul 2025via Institutional / Brokerage Research

Entry₹2,225.5Inferred
Target₹1,620
Total upside +27.21% (call closed)
Stop lossNot given
At expiry₹2,235.517 Jul 2026, 3:30 pm
Expired-0.45%
Follow ICICI Securities for new calls(67% target hit, 1026 closed calls)Get alertsWatch GLENMARK for new buy/sell callsGet alertsSee 5 active Long-term calls on GLENMARKSee 211 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 17 Jul 2026
0 supporting1 neutral2 opposing
Supports the SELL call (0)

Nothing found in this tip’s window yet.

Neutral / worth noting (1)

Nothing found in this tip’s window yet.

Weighs against the SELL call (2)

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·7 Jul · 1w ago

1 other SEBI-registered advisor has an active long-term BUY call on this stock

Advisor consensus · same horizon·1 Jun · 2mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Glenmark Pharmaceuticals

All analyst calls on Glenmark Pharmaceuticals

More from ICICI Securities

Every call and its outcome